H.B. Fuller Sees More M&A, But Not Yet
Share
H.B. Fuller CEO Celeste Mastin says deleveraging will be the company's priority after its planned acquisition of Advanced Medical Solutions, while maintaining M&A as part of its long-term strategy. She also tells Dani Burger on Bloomberg Open Interest that disruptions to petrochemical supplies have had a bigger impact than tariffs.
More from Australia
American Tungsten completes Nexus acquisition for Pinnacle MOU
Butn extends MYOB invoice financing agreement to 2027
Celsius Resources updates market on US$5M dispute
Estrella Resources signs sales deal for 27,000 tonnes
McPherson's reports $20.3M full year net loss
Novatti reaches €1.2B quarterly transaction volume